{"disease":{"id":"rss","name":"rss"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT07413029","title":"French National Cohort of Patients With PRSS1 Mutations","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT03956862","title":"GB001 in Adult Participants With Chronic Rhinosinusitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.","has_results":true},{"nct_id":"NCT04232085","title":"Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT04745247","title":"Stimulate the Face to Improve Tactile Acuity on the Hand","phase":"NA","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT01971957","title":"Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Nebraska","has_results":false},{"nct_id":"NCT03445650","title":"RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}